Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug
AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug
AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug
Submitted by
admin
on February 28, 2018 - 11:16am
Source:
Fierce Biotech
News Tags:
AstraZeneca
autoimmune disease
Viela Bio
spinoffs
biotech
Headline:
AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug
Do Not Allow Advertisers to Use My Personal information
